Consequently, CMS issued a completely new product code for casirivimab and imdevimab of 600 mg (Q0240) and a couple of new codes to the administration of repeat doses of casirivimab and imdevimab (M0240/M0241). Companies who administer casirivimab and imdevimab for PEP should use M0243 or M0244 for administering the main https://philx578ill7.wikiexcerpt.com/user